Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 28, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 28, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 9, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 9, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Apr 7, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 20, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 20, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jun 20, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 20, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 20, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 20, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 20, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 18, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 18, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 18, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 20, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 16, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 16, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 16, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 23, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 21, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 21, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 21, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 21, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 26, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 26, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 6, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 23, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 23, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 23, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 23, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 23, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 15, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 14, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 14, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 20, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 20, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 20, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 25, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 27, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs
Class 041
Providing information, namely, providing online, non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
Class 042
Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery
Class 044
Providing medical information in the fields of genetic medicine and drug delivery
Additional Information
Pseudo Mark
SELECTIVE ORGAN TARGETING LIPID NANOPARTICLE
Classification
International Classes
005
041
042
044